At Medmarc, the health and well being of our community is a top priority locally and abroad. We will continue to refer to the Centers for Disease Control and Prevention, the World Health Organization, and other public health agencies to determine the safest course of action for everyone. We also understand your business is relying on us to provide you with the protection and service you need for the coverage you have with us.
Medmarc has supported the life sciences industry for over 40 years and we will continue to do so. We are proud of our current insureds who are working so hard to combat this virus and keep us all safe, and we are ready to do our part to support their efforts as best we can.
We have developed this page to be a resource guide for our insureds and brokers and will continue to add as we navigate this very fluid situation.
Medmarc recognizes the potential for financial hardship to your business during this crisis. We will work with you and your broker to make reasonable accommodations to assist you should you need additional time to make premium payments. We will remain in compliance with the Departments of Insurance (DOI) for individual states which have guidance regarding grace periods. For a current list of relevant bulletins, please visit the National Association of Insurance Commissioners' Corona Virus Resource Center.
If you have any questions regarding premium payments or your account status, please let us know by contacting your broker or Medmarc directly. Visit Contact Us for a Medmarc representative in your state.
Medmarc currently does not anticipate any interruption to our services. Every claims representative has the ability to work remotely with full computer, phone, and support services. Regular mail processing will continue. You will be able to contact us through all means with the exception of in person meetings, and we will stay in contact with you. We have made preparations for staff to be fully functional during this timeframe.
If you have any questions about a pending claim, please call your claims representative assigned to you previously. Your claims representative is able to assist you with many questions you may have related to the status of your file, including whether your scheduled deposition, hearing, or trial may be postponed.
If you need to submit a claim, you can do so on our Report a Claim page.
Device manufacturers (as well as drug manufacturers, distributors, and health care providers) are struggling to answer many questions regarding their potential products liability in responding to the COVID-19 pandemic. Fortunately, as discussed below, the PREP Act and the recent declaration by the Secretary for the Department of Health and Human Services provides significant immunity from COVID-19 lawsuits. MORE...
With the Coronavirus (COVID-19) pandemic, medical device companies are facing disruptions to their supply chains, vendors who simply stop providing services, and a denuded work force. Who is responsible when the supply chain fails due to a pandemic? What should a company do when its vendors stop all work because their employees must stay home? And what can a company do when it can’t meet its supply obligations due to its own employees in quarantine? MORE...
FDA is working with U.S. Government partners, including CDC, and international partners to address the coronavirus disease 2019 (COVID-19) outbreak.
The Food and Drug Administration (FDA or Agency) plays a critical role in protecting the United States from threats including emerging infectious diseases, including the Coronavirus Disease 2019 (COVID-19) pandemic. FDA is committed to providing timely guidance to support continuity and response efforts to this pandemic.